Trade Gilead GILD

Gilead live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Julian Parker 2026 Jun 17, 16:02

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

forex
Julian Parker 2026 Jun 17, 16:01

SpaceX Stock Forecast 2027, 2031 and 2036: What the Lockup Schedule Means for SPCX Shares

stocks
Julian Parker 2026 Jun 16, 16:03

USD/CAD Forecast: Oil Weakness Keeps 1.4000 in Focus

forex
Julian Parker 2026 Jun 16, 16:01

Bitcoin and the Fed’s Guidance Shift: Short-Term Risk, Long-Term Narrative

crypto
Julian Parker 2026 Jun 16, 16:01

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

indices
Julian Parker 2026 Jun 15, 16:02

Silver Price Forecast: XAG/USD Holds Below $70 as Fed Decision Shapes Outlook

commodity
Julian Parker 2026 Jun 14, 16:05

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

cfd trading stocks
Julian Parker 2026 Jun 14, 16:02

How to Trade the SpaceX (SPCX) IPO Surge From South Africa With CFDs — Without Owning a Single Share

stocks
Julian Parker 2026 Jun 10, 16:01

SpaceX IPO Puts S&P 500 Inclusion Question in Focus

stocks
Noah Lee 2025 Nov 10, 09:10

x402 Ecosystem Competition Analysis: Launchpads, Facilitators, and Providers

Latest news

Show more
Julian Parker 2026 Jun 17, 16:05

Today's Stock Prices: U.S. Stocks Fall, SpaceX Slides, Allbirds Soars 39%

Stock
Julian Parker 2026 Jun 17, 16:04

Gold Price Today, June 18, 2026: Spot Gold Slides Toward $4,250 as Fed Signals Possible 2026 Rate Hike

gold price today
Julian Parker 2026 Jun 17, 16:04

Brent Oil Price Today: Brent Falls Below $79 as US-Iran Peace Deal Drains War Premium

Commodities
Julian Parker 2026 Jun 17, 16:02

Kevin Warsh’s First Fed Decision Turns Hawkish as Dot Plot Revives 2026 Rate Hike Bets

Forex
Julian Parker 2026 Jun 16, 16:05

Gold Price Today, June 17, 2026: Gold Holds Near One-Week High as Oil Slump Eases Fed Rate-Hike Fears

gold price today
Julian Parker 2026 Jun 16, 16:02

Brent Crude Falls Below $80 as Goldman Sachs and Morgan Stanley Cut Oil Forecasts

Commodities
Julian Parker 2026 Jun 16, 16:01

SpaceX Stock Rally Extends as Options Debut Fuels Post-IPO Surge

Stock
Julian Parker 2026 Jun 15, 16:04

Bank of Japan Raises Interest Rate to 1% as Yen Pressure Persists

Forex

Info

Spread

1.11

Spread (%)

0.9022 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

153656688640

Shares Outstanding

1241569874

Earnings Date (Next)

2013-01-28

Div Yield

2026-06-29

Ex-Dividend Date

2026-06-15

Forward annual dividend rate

3.28

Forward annual dividend yield

0.0258

EPS

7.35

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Jun 17, 16:03

How to Open a Swap-Free Account: Full Step-by-Step Guide

Julian Parker 2026 Jun 17, 16:01

Is Forex & CFD Trading Halal? The Ultimate Guide to Islamic Trading Account

Julian Parker 2026 Jun 16, 16:04

High-Leverage Forex Brokers: What Traders Need to Know Before Using High Leverage

Trustpilot